US-based Atreon is building a line of orthopedic products that provide a structure for improved healing of sports medicine injuries, in particular dedicated to advancing biologic solutions for musculoskeletal healing. Backed by more than 17 years of research and development, the company designs medical devices using electrospinning technology to produce synthetic nanofiber scaffolds that support and accelerate natural soft tissue repair. The company’s innovations are supported by a growing intellectual property portfolio of more than 50 issued and pending patents.